Spots Global Cancer Trial Database for lupron depot

Every month we try and update this database with for lupron depot cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study of Leuprolide to Treat Prostate Cancer	NCT00626431	Prostate Cancer	Leuprolide acet... Leuprolide acet...	18 Years -	Abbott
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids	NCT00683917	Uterine Fibroid...	Proellex 25 mg Proellex 50 mg Lupron Depot	18 Years - 45 Years	Repros Therapeutics Inc.
Ipilimumab + Androgen Depravation Therapy in Prostate Cancer	NCT01377389	Prostate Cancer	Ipilimumab Leuprolide Goserelin Degarelix	18 Years -	M.D. Anderson Cancer Center
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy	NCT00850941	Prostate Cancer	Questionnaire	18 Years -	M.D. Anderson Cancer Center
Neoadjuvant Ipilimumab in Prostate Cancer	NCT01194271	Prostate Cancer	Leuprolide Acet... Ipilimumab Radical Prostat...	18 Years -	M.D. Anderson Cancer Center
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)	NCT01642186	Fibrolamellar C... Fibrolamellar L...	everolimus letrozole plus ... combination of ...	12 Years -	Memorial Sloan Kettering Cancer Center
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)	NCT01642186	Fibrolamellar C... Fibrolamellar L...	everolimus letrozole plus ... combination of ...	12 Years -	Memorial Sloan Kettering Cancer Center
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer	NCT02059213	Prostate Cancer	Ibrance Bicalutamide Zoladex Lupron Depot	18 Years -	University of Michigan Rogel Cancer Center
Ipilimumab + Androgen Depravation Therapy in Prostate Cancer	NCT01377389	Prostate Cancer	Ipilimumab Leuprolide Goserelin Degarelix	18 Years -	M.D. Anderson Cancer Center
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation	NCT01746849	Leukemia Multiple Myelom... Myelodysplastic... Non-Hodgkin's L...	Palifermin Lupron peripheral bloo... Total-Body Irra... Thiotepa Cyclophosphamid... Degarelix	18 Years - 60 Years	Memorial Sloan Kettering Cancer Center
A Phase II Study of Androgen Deprivation Therapy With or Without Palbociclib in RB-Positive Metastatic Prostate Cancer	NCT02059213	Prostate Cancer	Ibrance Bicalutamide Zoladex Lupron Depot	18 Years -	University of Michigan Rogel Cancer Center
Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer	NCT01326312	Prostate Cancer	GTx-758 1000mg Lupron Depot GTx-758 2000mg	45 Years - 80 Years	GTx
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation	NCT01746849	Leukemia Multiple Myelom... Myelodysplastic... Non-Hodgkin's L...	Palifermin Lupron peripheral bloo... Total-Body Irra... Thiotepa Cyclophosphamid... Degarelix	18 Years - 60 Years	Memorial Sloan Kettering Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: